The name of the issuer is Colfax Corporation, a Delaware corporation (the “Issuer”).
Item 1(b) | Address of Issuer’s Principal Executive Offices: |
The principal executive office of the Issuer is 420 National Business Parkway, 5th Floor, Annapolis Junction, MD 20701.
Item 2(a) | Name of Person Filing: |
This Schedule is being filed by Steven M. Rales (the “Reporting Person”).
Item 2(b) | Address of Principal Business Office, or, if None, Residence: |
The principal business address of the Reporting Person is 2200 Pennsylvania Avenue, NW, Suite 800W, Washington, DC 20037.
The Reporting Person is a citizen of the United States of America.
Item 2(d) | Title of Class of Securities: |
This Schedule 13G/A relates to the common stock of the Issuer, par value $0.001 per share (the “Common Stock”).
The CUSIP Number of the Common Stock is 194014106.
Item 3 | If this statement is filed pursuant to§§240.13d-1(b) or240.13d-2(b) or (c), check whether the person filing is a: |
N/A
As of December 31, 2018, the total number of shares of Common Stock beneficially owned by the Reporting Person is 11,690,749. The Reporting Person’s ownership consists of 10,536,124 shares of Common Stock held directly by the Reporting Person, 375,000 shares of Common Stock owned by a charitable foundation, of which the Reporting Person is the sole director, 19,388 shares of Common Stock held by Capital Yield Corporation, of which the Reporting Person is a 50% stockholder, and 760,237 shares of Common Stock held by a family trust, of which the Reporting Person is the grantor. The Reporting Person disclaims beneficial ownership of those shares of Common Stock held by the charitable foundation.